Based on the reported tumor suppressor role of SIRT6, the decreased SIRT6 expression after treatment with HDAC inhibitor, TSA, reflects the complexity of developing HDAC inhibitor for cancer treatments (Figure 6). The gene discussed is HDAC9; the disease is neoplasm.